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Main text
Genotype imputation is a method where a study set of observed microarray based genotypes is extended using a set of sequenced or densely genotyped haplotypes from a set of reference haplotypes. Besides the quality and source of study genotypes, one of the crucial factors in the imputation precision is the size and quality of the reference panel. Global imputation panels have become a standard sources of reference haplotypes with the panels from 1000 Genomes Project While the large population-specific panels typically allow for high quality imputation 4, 5, 6 , the combination of population-specific panel and the global panel provides the largest number of successfully imputed variants 6, 7 . The larger number of reference haplotypes raises the proportion of high quality imputed variants, particularly in low minor allele frequencies.
Currently, there is also a large number of whole exome sequencing (WES) studies being carried out around the world. A good example is the recently published ExaC database 8 combining WES data from multiple populations. It is unclear, how much these large-scale whole exome resources contribute to the imputation quality of coding variants.
The focus of genetic association studies has shifted from common genetic variants (minor allele frequency, MAF > 5%) to rare-and low frequency variants that are more challenging to impute accurately because of low number of carrier haplotypes in the reference panels. with MAF < 1% for the imputation accuracy assessment.
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We tested the performance of these panels using a sample set of 10,489 individuals sampled from the National Finrisk Studies
12
.
The overall imputation quality, measured as the information score of IMPUTE2 software 13 , of the tested reference panels is compared in the Figure 1A . In the comparison, 1000G had more poorly imputed variants (high peak around zero) than wellimputed variants (high peak around one) whereas using HRC panel the proportion of wellimputed (info > 0.7) variants grew notably. Moreover, as can be seen from the figure, the density of the IMPUTE2 information scores was clearly shifting towards one when using the local reference panel consisting of Finnish samples compared to either of the global reference panels.
When looking only at the rare exonic variation, the total number of well-imputed (info > 0.7)
variants, with minor allele count (MAC) between 10 and 110 (comparable to a minor allele frequency between 0.05% and 0.5%), was higher when using HRC panel instead of the 1000G In addition to the number of well-imputed variants, we calculated the false positive rate for each of the panels. This was done by focusing on the imputed genotypes of monomorphic sites that were seen in the original Human CoreExome genotype data. In total we identified 8,160
monomorphic sites in Finns in the chromosome 17. The monomorphic sites that were imputed as 6 polymorphic (N = 898 with at least one heterozygous or minor allele homozygous genotype call with maximum posterior probability of > 0.9) were manually checked to be truly monomorphic using the genotyping array intensity data. We observed high false positive rates when using the global reference panels (4.0% for 1000G and 2.6% for HRC, Figure 1C) but not for the local reference panel. This result illustrates the difference between the Finnish genomes and more outbred populations with Finns having considerably less rare variants. When using global reference panels, many of these variants are falsely imputed to the target datasets.
The summary of the imputation of the exonic masked variation for the lowest allele count ranges When combining two panels with partially overlapping variants, like low-coverage WGS and high-coverage WES, the panels need to be cross-imputed as has been suggested for example by the UK10K working group 6 . In IMPUTE2 this can be done simply by adding extra option to the command line. However, this option should be used with care. When using this method with a global panel and a population specific panel (e.g. with 1000G and low-pass WGS), the false positive rate of variants increased considerably (7.4%, Figure 1C 
Online Methods
Study data set
Study data set comprises of 10,489 individuals from the National Finrisk study 12 . The individuals come from two separate genotyping projects. Individuals that were also in the reference data set 8 were removed before the imputation. Sample-wise quality control included checks for heterozygosity (± 3sd from mean F), gender discrepancies and call-rate < 98%. Marker-wise QC included removal of indels, duplicates, markers with HWE P-value < 10 -6 and markers with call rate < 95%. Genotyping algorithm used for both data sets was zCall 14 . The study data set was phased with ShapeIT2 15 using default options and effective population size of 11,418.
Finnish low-pass WGS reference data set
Sample quality control for the data was done at the Wellcome Trust Sanger Institute. SNPs with HWE P-value < 10 -5 (99,191) were removed and the data was phased using ShapeIT2 using default options and effective population size of 11,418. There were 38,666 markers with discordant alleles compared to 1000 genomes September 2013 reference panel. Only polymorphic autosomal SNPs were included in the reference panel.
Finnish WES reference data set
From the raw whole exome sequences variants were removed based on the following criteria: 1)
Non-biallelic variants removed, 2) Genotypes with QC < 20 were set to missing, 3) SNPs with call rate < 95% were removed, and 4) Monomorphic markers were removed. In addition, samples that were also in the WGS panel (7) were excluded together with individuals whose genotyping rate was < 95% (43). After filtering steps, the reference panel contains 222,342 markers and 4,932 individuals. The data was phased using ShapeIT2 using default options and effective population size of 11,418.
Imputation
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The chromosome 17 of study data set was imputed using all reference panels described above after masking variants with MAF < 1% for studying imputation accuracy and number of variants that can be imputed with good quality. In the case of non HRC reference panels, IMPUTE 13 version 2.3.1 was used with effective population size of 11,418 and Hidden Markov Model (HMM) states for imputation was set to the same value as the number of haplotypes in reference panels. HRC imputation was run with default settings using pre-phased study haplotypes.
Concordance calculation
The variant concordance rate was calculated using imputed best-guess genotypes with posterior probability > 0.9 which is often the default in different software transforming probability based data into genotype calls. We used GTOOL 
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